Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions

Although cancer immunotherapy is a compelling approach against cancer, its effectiveness is hindered by the challenge of generating a robust and durable immune response against metastatic cancer cells. Nanovaccines, specifically engineered to transport cancer antigens and immune-stimulating agents t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yueyi, Li, Shen, Jiang, Zedong, Tan, Keqin, Meng, Yuanling, Zhang, Dingyi, Ma, Xuelei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327386/
https://www.ncbi.nlm.nih.gov/pubmed/37415161
http://dx.doi.org/10.1186/s12951-023-01977-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327386/
https://www.ncbi.nlm.nih.gov/pubmed/37415161
http://dx.doi.org/10.1186/s12951-023-01977-1

Ejemplares similares